Tumors of the conjunctiva and cornea.
Shields CL, Shields JA.
Indian J Ophthalmol. 2019 Dec;67(12):1930-1948. doi: 10.4103/ijo.IJO_2040_19.
Medical treatment for ocular surface squamous neoplasia.
Monroy D, Serrano A, Galor A, Karp CL.
Eye (Lond). 2023 Apr;37(5):885-893. doi: 10.1038/s41433-023-02434-x. Epub 2023 Feb 8.
The Management of Ocular Surface Squamous Neoplasia (OSSN).
Yeoh CHY, Lee JJR, Lim BXH, Sundar G, Mehta JS, Chan ASY, Lim DKA, Watson SL, Honavar SG, Manotosh R, Lim CHL.
Int J Mol Sci. 2022 Dec 31;24(1):713. doi: 10.3390/ijms24010713.
Tumors of the ocular surface: A review.
Honavar SG, Manjandavida FP.
Indian J Ophthalmol. 2015 Mar;63(3):187-203. doi: 10.4103/0301-4738.156912.
Pathophysiology of ocular surface squamous neoplasia.
Gichuhi S, Ohnuma S, Sagoo MS, Burton MJ.
Exp Eye Res. 2014 Dec;129:172-82. doi: 10.1016/j.exer.2014.10.015. Epub 2014 Oct 18.
Ocular surface complications of local anticancer drugs for treatment of ocular tumors.
Moon J, Choi SH, Lee MJ, Jo DH, Park UC, Yoon SO, Woo SJ, Oh JY.
Ocul Surf. 2021 Jan;19:16-30. doi: 10.1016/j.jtos.2020.11.006. Epub 2020 Nov 22.
Spontaneous regression of ocular surface squamous neoplasia: Possible etiologic mechanisms in cancer resolution.
Theotoka D, Morkin MI, Naranjo A, Dubovy SR, Karp CL.
Ocul Surf. 2020 Jul;18(3):351-353. doi: 10.1016/j.jtos.2020.03.001. Epub 2020 Mar 10.
The role of imaging technologies for ocular surface tumors.
Venkateswaran N, Sripawadkul W, Karp CL.
Curr Opin Ophthalmol. 2021 Jul 1;32(4):369-378. doi: 10.1097/ICU.0000000000000771.
Bilateral ocular surface squamous neoplasia: A study of 25 patients and review of literature.
Vempuluru VS, Pattnaik M, Ghose N, Kaliki S.
Eur J Ophthalmol. 2022 Jan;32(1):620-627. doi: 10.1177/11206721211007109. Epub 2021 Apr 5.
Analysis of ocular surface and quality of life in patients with corneal and conjunctival tumors.
Magalhães AM, Vieira RP, Fernandes TJM, Rocha CDS, Higino T, Ventura CV, Cavalcanti CM.
Arq Bras Oftalmol. 2023 Mar-Apr;86(2):131-136. doi: 10.5935/0004-2749.20230036.
